Joan edukira
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Aurreratua
  • Mepolizumab For The Treatment...
  • Erreferentzia bihurtu
  • SMS
  • Bidali
  • Imprimir
  • Erregistroa esportatu
    • Nora RefWorks
    • Nora EndNoteWeb
    • Nora EndNote
  • Permanent link
Mepolizumab For The Treatment Of Patients With Eosinophilic Granulomatosis With Polyangiitis: A Phase Iii Randomized, Placebo-Controlled Trial

Mepolizumab For The Treatment Of Patients With Eosinophilic Granulomatosis With Polyangiitis: A Phase Iii Randomized, Placebo-Controlled Trial

Xehetasun bibliografikoak
Egile Nagusiak: Wechsler, M, Akuthota, P, Jayne, D, Khoury, P, Klion, A, Langford, C, Merkel, P, Moosig, F, Specks, U, Cid, M, Luqmani, R, Brown, J, Mallett, S, Philipson, R, Yancey, S, Steinfeld, J, Weller, P, Gleich, G
Formatua: Conference item
Argitaratua: American Thoracic Society 2017
  • Aleari buruzko argibideak
  • Deskribapena
  • Antzeko izenburuak
  • MARC erregistroa
Deskribapena
Gaia:

Antzeko izenburuak

  • Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis
    nork: Wechsler, M, et al.
    Argitaratua: (2017)
  • OP0130 Mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis: a phase iii randomised, placebo-controlled trial
    nork: Wechsler, M, et al.
    Argitaratua: (2017)
  • Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype
    nork: Benjamin Terrier, et al.
    Argitaratua: (2023-07-01)
  • Safety and Efficacy of Mepolizumab in Patients with Eosinophilic Granulomatosis with Polyangiitis
    nork: Ravi Ranjan Pradhan, et al.
    Argitaratua: (2019-01-01)
  • Real-life efficacy and safety of mepolizumab for eosinophilic granulomatosis with polyangiitis
    nork: Giuseppe A. Ramirez, et al.
    Argitaratua: (2022-12-01)

Bilaketa aukerak

  • Bilaketaren historia
  • Bilaketa aurreratua

Gehiago bilatu

  • Katalogoa arakatu
  • Bilaketa alfabetikoki
  • Esploratu kanalak
  • Erreserba egin ezazu
  • Berriak liburutegietan

Laguntza behar al duzu?

  • Bilaketa egiteko aholkuak
  • Galdetu liburuzainari
  • FAQ